IL32 and leprosy: NOD2 contributes to IL-32 production in response to M. leprae: MDP was able to drive IL-32–dependent differentiation of human DCs, promoting CD1b expression, and defects in this pathway correlated with M. leprae disease, providing biological grounds for the association of NOD2 polymorphisms with leprosy [41].